OTC Drugs-Of-Abuse Assay Firms Should Provide Confirmatory Testing - Panel
This article was originally published in The Tan Sheet
Executive Summary
FDA should require manufacturers of OTC screening tests for drugs-of-abuse to cover the cost of confirmatory testing for presumptive positive results, members of FDA's Clinical Chemistry & Clinical Toxicology Devices panel recommended.